• Nic Volker May Be Leading Edge of New Wave of Genetic Medicine

    Milwaukee-Wisconsin Journal Sentinel | The case of Nic Volker, a young undiagnosed patient in Wisconsin who was treated after exome sequencing revealed a specific genetic lesion, may be the leading edge of a wave moving across medicine, as doctors at the Medical College and Children's Hospital have half-a-dozen new cases moving through an evaulation process.

    Feb 28, 2011

  • Better Business, Better Compliance Through Defensible Data Disposal

    Bio-IT World Expert Commentary | Pharmaceutical companies are drowning in data, but few organizations know what to do about it. That’s about to change. A new information governance strategy that supports “defensible data disposal” can help companies reduce the amount of data they retain. By doing so, they can utilize research data more efficiently, improve compliance processes, reduce legal and business risk, and save money.

    Feb 23, 2011

  • Microsoft Mobile Health App Challenge

    Bio-IT World | Microsoft is extending a mobile challenge to the health and life sciences marketplace, and calling partners, developers and phone app enthusiasts to come up with unique apps coded for Windows Phone  7 (WP7) that will benefit their organizations, employees or consumers.

    Feb 23, 2011

  • Genedata Announces Software Suite for Biologics R&D

    Bio-IT World | SAN FRANCISO—Genedata today released Genedata Biologics, a first-in-class, off-the-shelf software solution for comprehensive data management and analysis of biologics R&D activities. The platform is featured at CHI’s Molecular Medicine Tri-Conference 2011 in San Francisco this week (Moscone Convention Center, Feb. 23-25).

    Feb 23, 2011

  • Context and the Cloud: the Third Era of Computing

    Forbes | IBM's Watson not only soundly beat two Jeopardy champions, but also may have ushered in a new era of computing, the third in IBM's long history.

    Feb 22, 2011

  • Obama Aims for Exascale

    Computerworld | President Obama has included supercomputing in his 2012 budget proposal. If the budget is approved, the Department of Energy will get $126 million for development of an exascale computing system.

    Feb 18, 2011

  • A 2011 Wakeup Call for Pharmaceutical Companies

    Bio-IT World Comment | Challenges are not new to the pharmaceutical industry. Will pharmaceutical companies get a break in 2011? What are the trends that are impacting the pharmaceutical industry? Here are our predictions for 2011.

    Feb 17, 2011

  • NetApp Talks Cloud

    Forbes | NetApp co-founder Dave Hitz talks about some of the challenges of cloud storage, how it changes business models and consolidation in the technology industry.

    Feb 16, 2011

  • Sanofi-Aventis Closes Genzyme Buy

    Forbes | Sanofi-Aventis has agreed to buy Cambridge-based Genzyme for $74 a share, valuing the biotech at $20.1 billion.

    Feb 16, 2011

  • Sun, Sand, and Sequencing at Marco Island

    NGS Leaders | Bio-IT World Editor Kevin Davies reports from Marco Island and the Advances in Genome Biology and Technology (AGBT) conference on Ion Torrent, Baylor, SOLiD's "sweet spot", PacBio, Illumina, and more.

    Feb 13, 2011

  • Gene Mutation Responsible for Common Hypertension

    HHMI | Howard Hughes Medical Institute (HHMI) scientists have used next-generation DNA sequencing tools to identify a mutation in a gene that underlies one of the most common forms of severe hypertension.

    Feb 13, 2011

  • Partnering with Pharma: A New CRO Approach

    Bio-IT World | Mike Wilkinson, CIO and executive vice president at PPD, has a message for pharma: “We’re in this together as partners; we’re not a vendor anymore. I think we need to move away from that kind of transactional approach where all they’re looking for is to have a vendor and buy a service. That’s not going to work in this environment.”

    Jan 26, 2011

  • High Performance Computing, GPUs, and Cloud: A Perfect Match?

    Bio-IT World | Guest Commentary | In 2010, the high performance and high throughput computing (HPC/HTC) communities saw two major technologies go mainstream: the use of general purpose graphical processing units (GPGPU or just GPUs) and Cloud computing.

    Jan 26, 2011

  • Realizing Value from Technology

    Bio-IT World | A former senior executive at Wyeth for many years, followed by spells at Millennium Pharmaceuticals and Infinity Pharmaceuticals, Susan Ward has spent the past eight years translating her detailed appreciation of the R&D process for numerous clients, helping companies translate technology into products. “Ask any CIO in the drug industry what keeps him/her up at night, and it won’t be too many sentences before the ‘value’ issue comes up,” says Ward.

    Jan 26, 2011

  • The Era of Big Data Analytics

    Bio-IT World | Toward the end of 2010, two systems biology (SB) pioneers, GNS Healthcare (formerly Gene Network Sciences) and Selventa (formerly Genstruct), underwent name changes and took major steps to reposition and grow their businesses. Time will judge the effectiveness of the moves. Today, the systems biology label seems mostly forgotten while its tenets live on, and perhaps that was to be expected.

    Feb 8, 2011

  • The $10,000 Genome and counting: The Complete Picture for 2011

    Bio-IT World | Complete Genomics CEO Cliff Reid says that the newly public genome sequencing service company is on course to sequence 1,000 human genomes by the end of 2011, and has already cracked the $10,000 genome "all in" pricepoint. Reid is also considering expanding Complete's range of service offerings and locations. 

    Feb 7, 2011

  • Oracle Builds Operational Efficiency, Empowers Patients

    Bio-IT World | Nicholas Giannasi is VP Life Sciences Product Strategy, sitting within Oracle’s Health Sciences global business unit, covering clinical development and safety. At Oracle, Giannasi has responsibility for the requirements, design, and direction of some 46 eClinical and safety products, including the recently acquired Phase Forward. Giannasi offered Bio•IT World chief editor Kevin Davies an overview of Oracle’s clinical offerings and aspirations, as well as steps to guard against complacency.

    Feb 7, 2011

  • Scientists Identify Druggable Target in Schizophrenia CNV

    Medscape | Scientists at UCSD have identified a copy number variant (CNV) in 1 in 300 schizophrenia patients that contains the gene for a known neuropeptide receptor called VIPR2, presenting a new and highly druggable target against the disorder. 

    Feb 4, 2011

  • Linking Data: New Life for Semantic Technologies

    Bio-IT World | A small software company formed by a group of former IBM staffers is breathing new life into semantic technologies. But don’t look for Cambridge Semantics to harp on the term. “The world of people well versed in semantic technology is still quite small,” says co-founder Lee Feigenbaum. “It’s important that anyone working with our software should not be IT... We can’t build our software without these technologies, but we’ve no interest in preaching that you’re using semantics.”

    Jan 26, 2011

  • A Prescription for Transforming Clinical Trials

    Bio-IT World | Becky Kush believes we still have work to do on clinical trials. The president and CEO of the Clinical Data Interchange Standards Consortium (CDISC) says, “We haven’t done the real transformational move yet that’s really new and different. And the process is broken.”

    Jan 26, 2011